Sclerosing therapy of internal hemorrhoids with a novel sclerosing agent. Comparison with ligation and excision

M Takano1, J Iwadare, H Ohba

  • 1Coloproctology Center, Takano Hospital, 4-2-88 Obiyama, Kumamoto 862-0924, Japan. m-takano@ku.magma.ne.jp

Insights

A new sclerosing agent, OC-108, offers a less invasive treatment for prolapsing internal hemorrhoids, showing similar prolapse disappearance rates to surgery but with fewer side effects.

Area of Science:

  • Gastroenterology
  • Colorectal Surgery
  • Pharmacological Treatments

Background:

  • Prolapsing internal hemorrhoids are a common condition.
  • Traditional surgical treatments like ligation and excision carry risks of pain and bleeding.
  • A novel sclerosing agent, OC-108, was developed for hemorrhoid treatment.

Purpose of the Study:

  • To evaluate the efficacy and safety of OC-108 for treating prolapsing internal hemorrhoids.
  • To compare OC-108 treatment outcomes with traditional surgical interventions.

Main Methods:

  • A comparative study involving patients aged 20 years and older with prolapsing internal hemorrhoids.
  • Treatment groups included the novel sclerosing agent OC-108 and conventional surgery (ligation and excision).
  • Data collected from ten Japanese medical institutions between October 2000 and October 2002.

Main Results:

  • At 28 days, prolapse disappearance rates were comparable: 94% for OC-108 versus 99% for surgery.
  • The 1-year recurrence rate was 16% for OC-108, which is considered satisfactory given its less invasive nature, compared to 2% for surgery.
  • Patients treated with OC-108 experienced significantly lower incidences of pain and bleeding.

Conclusions:

  • OC-108 presents a viable and less invasive alternative treatment option for patients with prolapsing internal hemorrhoids.
  • The agent demonstrates comparable efficacy in prolapse resolution with improved safety profile regarding pain and bleeding.
Abstract

Related Concept Videos

Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...